Lb Pharmaceuticals (LBRX) Current Assets (2024 - 2026)

Lb Pharmaceuticals' Current Assets history runs 3 years deep, the most recent figure standing at $389.1 million for Q1 2026.

• In Q1 2026, Current Assets changed N/A year-over-year to $389.1 million; the TTM figure through Mar 2026 stood at $389.1 million (changed N/A YoY), while the FY2025 annual figure was $308.4 million, up 968.01% from the prior year.
• Current Assets was $389.1 million for Q1 2026 at Lb Pharmaceuticals, up from $308.4 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $389.1 million in Q1 2026 to a low of $28.9 million in Q4 2024.
• Historically, Current Assets has averaged $260.7 million across 3 years, with a median of $312.4 million in 2025.
• Biggest YoY gain for Current Assets was 968.01% in 2025; the steepest drop was 968.01% in 2025.
• A 3-year view of Current Assets shows it stood at $28.9 million in 2024, then soared by 968.01% to $308.4 million in 2025, then rose by 26.15% to $389.1 million in 2026.
• The last three Current Assets figures came in at $389.1 million (Q1 2026), $308.4 million (Q4 2025), and $316.4 million (Q3 2025), per Business Quant data.